On Tuesday, JinkoSolar Holding Co., Ltd. (NYSE:JKS)’s shares declined -3.59% to $25.52.
JinkoSolar Holding Co., Ltd. (JKS) a global leader in the solar PV industry, declared that its wholly owned partner, JinkoSolar (U.S.) INC., (“JinkoSolar US”), has signed amendments to the credit agreement with Wells Fargo Bank, National Association (“Wells Fargo”). Under the new terms of the credit agreement, JinkoSolar US’s credit limit will be raised to $40 million from $20 million.
JinkoSolar Holding Co., Ltd., together with its auxiliaries, engages in the design, development, production, and marketing of photovoltaic products in the People’s Republic of China and internationally. The company operates through two segments, Manufacturing and Solar Power Projects. It offers solar modules, solar cells, silicon ingots and silicon wafers, and recovered silicon materials.
Allstate Corp (NYSE:ALL)’s shares gained 1.40% to $65.72.
The Confederation of North, Central America and Caribbean Association Football declared that Allstate Insurance Company will be the Official Protector of the Gold Cup™ trophy as it makes its way to some of the biggest soccer matches across the country. The seven-city Gold Cup Trophy tour planned for this month, gives soccer fans across the United States the chance to interact with the Cup awarded to the winner of the region’s preeminent men’s national team soccer tournament.
Allstate, an official sponsor of the Gold Cup, will kick off the trophy tour recently in Dallas ahead of the opening match at Toyota Stadium, during which defending 2013 champion United States takes on Honduras as part of a double header, also featuring 2013 runner-up Panama as compared to Haiti.
The Allstate Corporation, through its auxiliaries, engages in the property-liability insurance and life insurance businesses in the United States and Canada. The company’s Allstate Protection segment sells private passenger auto and homeowners insurance products under the Allstate, Encompass, Esurance brand names. It also provides specialty auto products, counting motorcycle, trailer, motor home, and off-road vehicle insurance policies; other personal lines products comprising renter, condominium, landlord, boat, umbrella, and manufactured home insurance policies; roadside assistance products; and commercial products for small business owners, in addition to insurance agency services. In addition, this segment sells retirement and investment products, counting mutual funds, fixed and variable annuities, disability insurance, and long-term care insurance products. Further, it sells its products through contact centers and Internet.
At the end of Tuesday’s trade, Paychex, Inc. (NASDAQ:PAYX)‘s shares dipped -0.33% to $48.01.
Paychex, Inc. (PAYX) declared it will offer a live webcast of the company’s Investor Day on Wednesday, July 15, 2015. Making presentations during this year’s Investor Day will be:
- Martin Mucci, President and CEO
- Mark Bottini, Senior Vice President—Sales
- Andrew Childs, Vice President—Marketing
- Michael Gioja, Senior Vice President—Information Technology, Product Administration and Development
- Efrain Rivera, Senior Vice President, Chief Financial Officer and Treasurer
The webcast will start at 11:30 a.m. Eastern time and conclude at about 2:30 p.m. following a listen-only question and answer session with members of the Paychex senior administration team.
Paychex, Inc. provides payroll, human resource, insurance, and benefits outsourcing solutions for small to medium-sized businesses in the United States and Germany. The company offers payroll processing services that comprise the calculation, preparation, and delivery of employee payroll checks; production of internal accounting records and administration reports; preparation of federal, state, and local payroll tax returns; and collection and remittance of clients payroll obligations.
Novo Nordisk A/S (ADR) (NYSE:NVO), ended its Tuesday’s trading session with -0.88% loss, and closed at $54.30.
In continuation of the company`s declarements dated 30 January 2015 and 30 April 2015 concerning planned share repurchase programs, and following Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NVO) and its wholly-owned associates on 30 June 2015 owned 27,609,691 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,521,938 or 1.1% of the total share capital.
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, in addition to other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
